SAB Biotherapeutics (SABS) Misses Q2 EPS by 79c
Tweet
Share
E-mailGet Alerts SABS Hot Sheet
Join SI Premium – FREE
SAB Biotherapeutics (NASDAQ: SABS) reported Q2 EPS of ($0.79).
For earnings history and earnings-related data on SAB Biotherapeutics (SABS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore ISI Starts Credo Tech (CRDO) at Outperform
- SpaceX (SPCX) call put ratio 1 call to 1 put on 1.9M contracts
- FedEx (FDX) call put ratio 1 call to 1.8 puts into quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
